首页> 外文期刊>Journal of Molecular Biology >Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated protein C: Role of magnesium at physiological calcium
【24h】

Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated protein C: Role of magnesium at physiological calcium

机译:VIIa因子和活化蛋白C的γ-羧基谷氨酸结构域的结构和功能研究:镁在生理钙中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Crystal structures of factor (F) VIIa/soluble tissue factor (TF), obtained under high Mg2 + (50 mM Mg2 +/5 mM Ca2 +), have three of seven Ca2 + sites in the γ-carboxyglutamic acid (Gla) domain replaced by Mg2 + at positions 1, 4, and 7. We now report structures under low Mg2 + (2.5 mM Mg2 +/5 mM Ca 2 +) as well as under high Ca2 + (5 mM Mg2 +/45 mM Ca2 +). Under low Mg2 +, four Ca2 + and three Mg2 + occupy the same positions as in high-Mg2 + structures. Conversely, under low Mg2 +, reexamination of the structure of Gla domain of activated Protein C (APC) complexed with soluble endothelial Protein C receptor (sEPCR) has position 4 occupied by Ca 2 + and positions 1 and 7 by Mg2 +. Nonetheless, in direct binding experiments, Mg2 + replaced three Ca2 + sites in the unliganded Protein C or APC. Further, the high-Ca2 + condition was necessary to replace Mg4 in the FVIIa/soluble TF structure. In biological studies, Mg2 + enhanced phospholipid binding to FVIIa and APC at physiological Ca2 +. Additionally, Mg2 + potentiated phospholipid-dependent activations of FIX and FX by FVIIa/TF and inactivation of activated factor V by APC. Since APC and FVIIa bind to sEPCR involving similar interactions, we conclude that under the low-Mg2 + condition, sEPCR binding to APC-Gla (or FVIIa-Gla) replaces Mg4 by Ca4 with an attendant conformational change in the Gla domain ω-loop. Moreover, since phospholipid and sEPCR bind to FVIIa or APC via the ω-loop, we predict that phospholipid binding also induces the functional Ca4 conformation in this loop. Cumulatively, the data illustrate that Mg2 + and Ca 2 + act in concert to promote coagulation and anticoagulation.
机译:在高Mg2 +(50 mM Mg2 + / 5 mM Ca2 +)下获得的因子(F)VIIa /可溶性组织因子(TF)的晶体结构在γ-羧基谷氨酸(Gla)域中有七个Ca2 +位点中的三个在位置1、4和7处被Mg2 +取代。我们现在报告低Mg2 +(2.5 mM Mg2 + / 5 mM Ca 2 +)以及高Ca2 +(5 mM Mg2 + / 45 mM Ca2 +下的结构)。在低Mg2 +下,四个Ca2 +和三个Mg2 +占据与高Mg2 +结构相同的位置。相反,在低Mg2 +浓度下,与可溶性内皮蛋白C受体(sEPCR)复合的活化蛋白C(APC)的Gla结构域的结构重新检查,Ca 2 +占据4位,Mg2 +占据1和7位。但是,在直接结合实验中,Mg2 +取代了未配体的C蛋白或APC中的三个Ca2 +位点。此外,必须使用高Ca2 +条件来替换FVIIa /可溶性TF结构中的Mg4。在生物学研究中,Mg2 +在生理Ca2 +处增强了与FVIIa和APC的磷脂结合。另外,Mg2 +通过FVIIa / TF增强了FIX和FX的磷脂依赖性激活,并通过APC激活了活化的因子V。由于APC和FVIIa与sEPCR结合并涉及相似的相互作用,因此我们得出结论,在低Mg2 +条件下,与APC-Gla(或FVIIa-Gla)结合的sEPCR用Ca4取代Mg4,伴随着Gla结构域ω环的构象变化。此外,由于磷脂和sEPCR通过ω环与FVIIa或APC结合,我们预测磷脂结合也会在此环中诱导功能性Ca4构象。累积地,数据表明Mg2 +和Ca 2 +协同作用以促进凝结和抗凝。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号